Trulieve Cannabis Corp. made history by becoming the first U.S. cannabis company to list on the New York Stock Exchange under the ticker TRLV. This milestone was enabled by the Trump administration's reclassification of cannabis to Schedule III for medical use, allowing Trulieve to meet NYSE listing requirements by separating its medical and adult-use operations. The listing marks a significant shift in the cannabis industry, potentially opening the door for more companies to access institutional capital. Investors are also watching an upcoming DEA hearing that could further ease federal restrictions on cannabis.
Scottish brewer BrewDog, owned by Tilray Brands, has introduced 24 American craft beers to the U.K. market, available initially through BrewDog bars and online. This launch includes popular U.S. brands like SweetWater, Montauk, and Shock Top, marking...
Tilray Medical Germany has introduced ARX™, its first premium medical cannabis brand developed and cultivated in Germany. The brand combines genetics from Canada's Broken Coast with German cultivation expertise, produced under strict EU-GMP standards...
